Functional aspects of Toll-like receptor/MyD88 signalling during protozoan infection: Focus on Toxoplasma gondii

Clinical and Experimental Immunology

Volumn 156, Issue 1, 2009, Pages 17-24

  Egan, C E ^a   Sukhumavasi, W ^a   Butcher, B A ^a   Denkers, E Y ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

Infection protozoan; Innate immunity; Toll like receptor

Indexed keywords

INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9;

ADAPTIVE IMMUNITY; ARTICLE; CELL ACTIVITY; EFFECTOR CELL; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE RESPONSE; INFECTION CONTROL; INFECTION PREVENTION; INNATE IMMUNITY; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TOXOPLASMA GONDII; TOXOPLASMOSIS; VACCINATION;

ANIMALS; HOST-PARASITE INTERACTIONS; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, MUCOSAL; LIGANDS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS; TOXOPLASMA; TOXOPLASMOSIS;

EID: 61849107102     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2009.03876.x     Document Type: Article

References (95)

1. Janeway CA, Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002 20 : 197 216.
2. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006 124 : 783 801.
3. Peterson E, Liesenfeld O. Clinical disease and diagnostics. In : Weiss LM, Kim K, eds. Toxoplasma gondii. The model apicomplexan: perspectives and methods. Amsterdam : Academic Press, 2007 : 81 100.
4. Gazzinelli RT, Denkers EY. Protozoan encounters with Toll-like receptor signalling pathways: implications for host parasitism. Nat Rev Immunol 2006 6 : 895 906.
5. Pfaff AW, Liesenfeld O, Candolfi E. Congenital toxoplasmosis. In : Ajioka JW, Soldati D, eds. Toxoplasma: molecular and cellular biology. Norfolk : Horizon Bioscience, 2007 : 93 110.
6. Hill DE, Chirukandoth S, Dubey JP. Biology and epidemiology of Toxoplasma gondii in man and animals. Anim Health Res Rev 2005 6 : 41 61.
7. Denkers EY, Gazzinelli RT. Regulation and function of T cell-mediated immunity during Toxoplasma gondii infection. Clin Microbiol Rev 1998 11 : 569 88.
8. Pepper M, Hunter CA. Innate immune recognition and regulation of protective immunity to Toxoplasma gondii. In : Ajioka JW, Soldati D, eds. Toxoplasma: molecular and cellular biology. Norfolk : Horizon Bioscience, 2007 : 111 26.
9. Kawai T, Akira S. TLR signaling. Semin Immunol 2007 19 : 24 32.
10. Akira S, Takeda T. Toll-like receptor signaling. Nat Rev Immunol 2004 4 : 499 511.
11. Akira S. Toll-like receptor signaling. J Biol Chem 2003 278 : 38105 8.
12. Barton GM, Kagan JC, Medzhitov R. Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat Immunol 2006 7 : 49 56.
13. Kawai T, Adachi O, Ogawa T, Takeda K, Akira S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 1999 11 : 115 22.
14. O'Neill LA, Bowie AG. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat Rev Immunol 2007 7 : 353 64.
15. Yamamoto M, Sato S, Hemmi H et al. Role of adaptor TRIF in the MyD88-independent Toll-like receptor pathway. Science 2003 301 : 640 3.
16. O'Neill LA. When signaling pathways collide: positive and negative regulation of Toll-like receptor signal transduction. Immunity 2008 29 : 12 20.
17. Wald D, Qin J, Zhao Z et al. SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling. Nat Immunol 2003 4 : 920 7.
18. Janssens S, Burns K, Vercammen E, Tschopp J, Beyaert R. MyD88S, a splice variant of MyD88, differentially modulates NF-kappaB- and AP-1-dependent gene expression. FEBS Lett 2003 548 : 103 7.
19. Kobayashi K, Hernandez LD, Galan JE, Janeway CA Jr., Medzhitov R, Flavell RA. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 2002 110 : 191 202.
20. Mansell A, Smith R, Doyle SL et al. Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation. Nat Immunol 2006 7 : 148 55.
21. Bartholomeu DC, Ropert C, Melo MB et al. Recruitment and endo-lysosomal activation of TLR9 in dendritic cells infected with Trypanosoma cruzi. J Immunol 2008 181 : 1333 44.
22. Harris TH, Cooney NM, Mansfield JM, Paulnock DM. Signal transduction, gene transcription, and cytokine production triggered in macrophages by exposure to trypanosome DNA. Infect Immun 2006 74 : 4530 7.
23. Ivory CP, Prystajecky M, Jobin C, Chadee K. Toll-like receptor 9-dependent macrophage activation by Entamoeba histolytica DNA. Infect Immun 2008 76 : 289 97.
24. Liese J, Schleicher U, Bogdan C. TLR9 signaling is essential for the innate NK cell response in murine cutaneous leishmaniasis. Eur J Immunol 2007 37 : 3424 34.
25. Parroche P, Lauw FN, Goutagny N et al. Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9. Proc Natl Acad Sci USA 2007 104 : 1919 24.
26. Campos MAS, Almeida IC, Takeuchi O et al. Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite. J Immunol 2001 167 : 416 23.
27. de Veer MJ, Curtis JM, Baldwin TM et al. MyD88 is essential for clearance of Leishmania major: possible role for lipophosphoglycan and Toll-like receptor 2 signaling. Eur J Immunol 2003 33 : 2822 31.
28. Gazzinelli RT, Ropert C, Campos MA. Role of the Toll/interleukin-1 receptor signaling pathway in host resistance and pathogenesis during infection with protozoan parasites. Immunol Rev 2004 201 : 9 25.
29. Krishnegowda G, Hajjar AM, Zhu J et al. Induction of proinflammatory responses in macrophages by the glycosylphosphatidylinositols of Plasmodium falciparum: cell signaling receptors, glycosylphosphatidylinositol (GPI) structural requirement, and regulation of GPI activity. J Biol Chem 2005 280 : 8606 16.
30. Oliveira AC, Peixoto JR, de Arruda LB et al. Expression of functional TLR4 confers proinflammatory responsiveness to Trypanosoma cruzi glycoinositolphospholipids and higher resistance to infection with T. cruzi. J Immunol 2004 173 : 5688 96.
31. Scanga CA, Aliberti J, Jankovic D et al. Cutting edge: MyD88 is required for resistance to Toxoplasma gondii infection and regulates parasite-induced IL-12 production by dendritic cells. J Immunol 2002 168 : 5997 6001.
32. Del Rio L, Butcher BA, Bennouna S, Hieny S, Sher A, Denkers EY. Toxoplasma gondii triggers MyD88-dependent and CCL2(MCP-1) responses using distinct parasite molecules and host receptors. J Immunol 2004 172 : 6954 60.
33. Yarovinsky F, Zhang D, Anderson JF et al. TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science 2005 308 : 1626 9.
34. Yarovinsky F. Toll-like receptors and their role in host resistance to Toxoplasma gondii. Immunol Lett 2008 119 : 17 21.
35. Zhang D, Zhang G, Hayden MS et al. A Toll-like receptor that prevents infection by uropathogenic bacteria. Science 2004 303 : 1522 6.
36. Plattner F, Yarovinsky F, Romero S et al. Toxoplasma profilin is essential for host cell invasion and TLR dependent induction of interleukin-12. Cell Host Microbe 2008 14 : 77 87.
37. Rosenberg B, Juckett DA, Aylsworth CF et al. Protein from intestinal Eimeria protozoan stimulates IL-12 release from dendritic cells, exhibits antitumor properties in vivo and is correlated with low intestinal tumorigenicity. Int J Cancer 2005 114 : 756 65.
38. Wichroski MJ, Ward GE. Biosynthesis of glycosylphosphatidylinositol is essential to the survival of the protozoan parasite Toxoplasma gondii. Eukaryot Cell 2003 2 : 1132 6.
39. Debierre-Grockiego F, Azzouz N, Schmidt J et al. Roles of glycosylphosphatidylinositols of Toxoplasma gondii. Induction of TNF-α production in macrophages. J Biol Chem 2003 278 : 32987 93.
40. Debierre-Grockiego F, Campos MA, Azzouz N et al. Activation of TLR2 and TLR4 by glycosylphosphatidylinositols derived from Toxoplasma gondii. J Immunol 2007 179 : 1129 37.
41. Hitziger N, Dellacasa I, Albiger B, Barragan A. Dissemination of Toxoplasma gondii to immunoprivileged organs and role of Toll/interleukin-1 receptor signalling for host resistance assessed by in vivo bioluminsecence imaging. Cell Microbiol 2005 6 : 837 48.
42. Sukhumavasi W, Egan CE, Warren AL et al. TLR adaptor MyD88 is essential for pathogen control during oral Toxoplasma gondii infection but not adaptive immunity induced by a vaccine strain of the parasite. J Immunol 2008 181 : 3464 73.
43. Mun H-S, Aosai F, Norose K et al. TLR2 as an essential molecule for protective immunity against Toxoplasma gondii infection. Int Immunol 2003 15 : 1081 7.
44. Bafica A, Santiago HC, Goldszmid R, Ropert C, Gazzinelli RT, Sher A. Cutting edge: TLR9 and TLR2 signaling together account for MyD88-dependent control of parasitemia in Trypanosoma cruzi infection. J Immunol 2006 177 : 3515 19.
45. Bafica A, Scanga CA, Feng CG, Leifer C, Cheever A, Sher A. TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis. J Exp Med 2005 202 : 1715 24.
46. Gazzinelli RT, Hieny S, Wynn T, Wolf S, Sher A. IL-12 is required for the T-cell independent induction of IFN-γ by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc Natl Acad Sci USA 1993 90 : 6115 19.
47. Scharton-Kersten T, Yap G, Magram J, Sher A. Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii. J Exp Med 1997 185 : 1 13.
48. Taylor GA. IRG proteins key mediators of interferon-regulated host resistance to intracellular pathogens. Cell Microbiol 2007 9 : 1099 107.
49. Lebeis SL, Bommarius B, Parkos CA, Sherman MA, Kalman D. TLR signaling mediated by MyD88 is required for a protective innate immune response by neutrophils to Citrobacter rodentium. J Immunol 2007 179 : 566 77.
50. Rodriguez N, Fend F, Jennen L et al. Polymorphonuclear neutrophils improve replication of Chlamydia pneumoniae in vivo upon MyD88-dependent attraction. J Immunol 2005 174 : 4836 44.
51. Kabelitz D, Medzhitov R. Innate immunity - cross-talk with adaptive immunity through pattern recognition receptors and cytokines. Curr Opin Immunol 2007 19 : 1 3.
52. Pasare C, Medzhitov R. Toll-dependent control mechanisms of CD4 T cell activation. Immunity 2004 21 : 733 41.
53. Schnare M, Barton GM, Holt AC, Takeda K, Akira S, Medzhitov R. Toll-like receptors control activation of adaptive immune responses. Nat Immunol 2001 2 : 947 50.
54. Yarovinsky F, Kanzler H, Hieny S, Coffman RL, Sher A. Toll-like receptor recognition regulates immunodominance in an antimicrobial CD4+ T cell response. Immunity 2006 25 : 655 64.
55. Larosa DF, Stumhofer JS, Gelman AE et al. T cell expression of MyD88 is required for resistance to Toxoplasma gondii. Proc Natl Acad Sci USA 2008 105 : 3855 60.
56. Bolz DD, Sundsbak RS, Ma Y et al. MyD88 plays a unique role in host defense but not arthritis development in Lyme disease. J Immunol 2004 173 : 2003 10.
57. Kursar M, Mittrucker HW, Koch M, Kohler A, Herma M, Kaufmann SH. Protective T cell response against intracellular pathogens in the absence of Toll-like receptor signaling via myeloid differentiation factor 88. Int Immunol 2004 16 : 415 21.
58. von Bernuth H, Picard C, Jin Z et al. Pyogenic bacterial infections in humans with MyD88 deficiency. Science 2008 321 : 691 6.
59. Way SS, Kollmann TR, Hajjar AM, Wilson CB. Cutting edge: protective cell-mediated immunity to Listeria monocytogenes in the absence of myeloid differentiation factor 88. J Immunol 2003 171 : 533 7.
60. Kim L, Butcher BA, Lee CW, Uematsu S, Akira S, Denkers EY. Toxoplasma gondii genotype determines MyD88-dependent signaling in infected macrophages. J Immunol 2006 177 : 2584 91.
61. + T cell-dependent, IFN-γ-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii. J Exp Med 1996 184 : 597 607.
62. Jankovic D, Kullberg MC, Feng CG et al. Conventional T-bet+Foxp3- Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. J Exp Med 2007 204 : 273 83.
63. Liesenfeld O. Oral infection of C57BL/6 mice with Toxoplasma gondii: a new model of inflammatory bowel disease? J Infect Dis 2002 185 : S96 101.
64. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007 448 : 427 34.
65. Heimesaat MM, Bereswill S, Fischer A et al. Gram-negative bacteria aggravate murine small intestinal Th1-type immunopathology following oral infection with Toxoplasma gondii. J Immunol 2006 177 : 8785 95.
66. Heimesaat MM, Fischer A, Jahn HK et al. Exacerbation of murine ileitis by Toll-like receptor 4 mediated sensing of lipopolysaccharide from commensal Escherichia coli. Gut 2007 56 : 941 8.
67. Liesenfeld O, Kang H, Park D et al. TNF-α, nitric oxide and IFN-γ are all critical for development of necrosis in the small intestine and early mortality in genetically susceptible mice infected perorally with Toxoplasma gondii. Parasite Immunol 1999 21 : 365 76.
68. Furuta T, Kikuchi T, Akira S, Watanabe N, Yoshikawa Y. Roles of the small intestine for induction of Toll-like receptor 4-mediated innate resistance in naturally acquired murine toxoplasmosis. Int Immunol 2006 18 : 1655 62.
69. Minns LA, Menard LC, Foureau DM et al. TLR9 is required for the gut-associated lymphoid tissue response following oral infection of Toxoplasma gondii. J Immunol 2006 176 : 7589 97.
70. Denkers EY, Kim L, Butcher BA. In the belly of the beast: subversion of macrophage proinflammatory signaling cascades during Toxoplasma gondii infection. Cell Microbiol 2003 5 : 75 83.
71. Shapira S, Harb OS, Caamano J, Hunter CA. The NF-kappaB signaling pathway: immune evasion and immunoregulation during toxoplasmosis. Int J Parasitol 2004 34 : 393 400.
72. Butcher BA, Denkers EY. Mechanism of entry determines ability of Toxoplasma gondii to inhibit macrophage proinflammatory cytokine production. Infect Immun 2002 70 : 5216 24.
73. Butcher BA, Kim L, Johnson PF, Denkers EY. Toxoplasma gondii tachyzoites inhibit proinflammatory cytokine induction in infected macrophages by preventing nuclear translocation of the transcription factor NFκB. J Immunol 2001 167 : 2193 201.
74. Shapira SS, Speirs K, Gerstein A, Caamano J, Hunter CA. Suppression of NF-κB activation by infection with Toxoplasma gondii. J Infect Dis 2002 185 : S66 72.
75. Shapira S, Harb O, Margarit J et al. Initiation and termination of NFκB signaling by the intracellular protozoan parasite Toxoplasma gondii. J Cell Sci 2005 118 : 3501 8.
76. Kim L, Butcher BA, Denkers EY. Toxoplasma gondii interferes with lipopolysaccharide-induced mitogen-activated protein kinase activation by mechanisms distinct from endotoxin tolerance. J Immunol 2004 172 : 3003 10.
77. Lee CW, Bennouna S, Denkers EY. Screening for Toxoplasma gondii regulated transcriptional responses in LPS-activated macrophages. Infect Immun 2006 74 : 1916 23.
78. Leng J, Butcher BA, Egan CE, Abi Abdallah DS, Denkers EY. Toxoplasma gondii prevents chromatin remodeling initiated by Toll-like receptor-triggered macrophages activation. J Immunol 2009 182 : 489 97.
79. Saeij JP, Coller S, Boyle JP, Jerome ME, White MW, Boothroyd JC. Toxoplasma co-opts host gene expression by injection of a polymorphic kinase homologue. Nature 2007 445 : 324 7.
80. Pepper M, Dzierszinski F, Wilson E et al. Plasmacytoid dendritic cells are activated by Toxoplasma gondii to present antigen and produce cytokines. J Immunol 2008 180 : 6229 36.
81. Bierly AL, Shufesky WJ, Sukhumavasi W, Morelli A, Denkers EY. Dendritic cells expressing plasmacytoid marker PDCA-1 are Trojan horses during Toxoplasma gondii infection. J Immunol 2008 181 : 8445 91.
82. Aliberti J, Reis e Sousa C, Schito M et al. CCR5 provides a signal for microbial induced production of IL-12 by CD8α+ dendritic cells. Nat Immunol 2000 1 : 83 7.
83. Aliberti J, Valenzuela JG, Carruthers VB et al. Molecular mimicry of a CCR5 binding-domain in the microbial activation of dendritic cells. Nat Immunol 2003 4 : 485 90.
84. Kim L, Denkers EY. Toxoplasma gondii triggers Gi-dependent phosphatidylinositol 3-kinase signaling required for inhibition of host cell apoptosis. J Cell Sci 2006 119 : 2119 26.
85. Luder CGK, Gross U. Apoptosis and its modulation during infection with Toxoplasma gondii: molecular mechanisms and role in pathogenesis. Curr Top Microbiol Immunol 2005 289 : 219 38.
86. Lee CW, Sukhumavasi W, Denkers EY. Phosphoinositide-3-kinase-dependent, MyD88-independent induction of CC-type chemokines characterizes the macrophage response to Toxoplasma gondii strains with high virulence. Infect Immun 2007 75 : 5788 97.
87. Butcher BA, Kim L, Panopoulos A, Watowich SS, Murray PJ, Denkers EY. Cutting edge: IL-10-independent STAT3 activation by Toxoplasma gondii mediates suppression of IL-12 and TNF-α in host macrophages. J Immunol 2005 174 : 3148 52.
88. Pashine A, Valiante NM, Ulmer JB. Targeting the innate immune response with improved vaccine adjuvants. Nat Med 2005 11 : S63 8.
89. Schofield L, Hewitt MC, Evans K, Siomos A, Seeberger PH. Synthetic GPI as a candidate anti-toxic vaccine in a model of malaria. Nature 2002 418 : 785 9.
90. Chaudhuri N, Whyte MK, Sabroe I. Reducing the toll of inflammatory lung disease. Chest 2007 131 : 1550 6.
91. Goldman M. Translational mini-review series on Toll-like receptors: Toll-like receptor ligands as novel pharmaceuticals for allergic disorders. Clin Exp Immunol 2007 147 : 208 16.
92. Eder W, Klimecki W, Yu L et al. Toll-like receptor 2 as a major gene for asthma in children of European farmers. J Allergy Clin Immunol 2004 113 : 482 8.
93. Lazarus R, Raby BA, Lange C et al. Toll-like receptor 10 genetic variation is associated with asthma in two independent samples. Am J Respir Crit Care Med 2004 170 : 594 600.
94. Creticos PS, Schroeder JT, Hamilton RG et al. Immunotherapy with a ragweed-Toll-like receptor 9 agonist vaccine for allergic rhinitis. N Engl J Med 2006 355 : 1445 55.
95. Ehlers M, Ravetch JV. Opposing effects of Toll-like receptor stimulation induce autoimmunity or tolerance. Trends Immunol 2007 28 : 74 9.